Mostrar los filtros
Tipo de recursos
Filtrado por Tipo de recursos
Patologías
Filtrado por Patologías
Tecnologias
Filtrado por Tecnologias
Instrumentos
Filtrado por Instrumentos
68 Resultados encontrados
Ordenar por:

Sebia receives U.S. FDA Clearance for the FLC Kappa & Lambda assays

Comunicado de Prensa
Mar. 07, 2024

Expanding offering for Multiple Myeloma and AL Amyloidosis Testing.

How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis

Webinar
Feb. 21, 2024

Educational Workshop with Dr. Barbara De la Salle

HYDRASYS 2 SCAN FOCUSING: Overview

Video
Feb. 13, 2024

Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.

Sebia launches M-inSight®, a test for monitoring multiple myeloma patients

Comunicado de Prensa
Dic. 04, 2023

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma

Autoinmunidad y cáncer : Cruce de caminos en la disregulación del sistema inmunitario

Webinar
Dic. 01, 2023

Autoinmunidad y Cáncer : aproximación inteligente al diagnóstico y tratamiento de enfermedades derivadas de las células plasmáticas

Dic. 09, 2023 Dic. 11, 2023

Evento
San Diego, CA

ASH 2023

Sebia booth: #2455

Saber más

Current Status of Detecting Monoclonal Antibodies and Free Light Chains in Serum

Webinar
Ago. 31, 2023

Educational Webinar with Dr. Matthias Orth from University of Heidelberg at University Hospital Mannheim.

Improving the diagnosis of AATD with aid of Serum Protein Electrophoresis

Webinar
Ago. 23, 2023

Educational Workshop with Dr. Ilaria Ferrarotti